The endogenous pro-resolving mediators lipoxin A4 and resolvin E1 preserve organ function in allograft rejection.

[1]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[2]  J. Takeda,et al.  The Anti-Inflammatory and Proresolving Mediator Resolvin E1 Protects Mice from Bacterial Pneumonia and Acute Lung Injury , 2009, The Journal of Immunology.

[3]  M. Perretti,et al.  Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis , 2009, Nature.

[4]  L. Glimcher,et al.  A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy , 2008, The Journal of experimental medicine.

[5]  C. Serhan,et al.  Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  B. Levy,et al.  Resolvin E1 regulates interleukin 23, interferon-γ and lipoxin A4 to promote the resolution of allergic airway inflammation , 2008, Nature Immunology.

[7]  C. Serhan,et al.  Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  Charles N. Serhan,et al.  Resolvin E1 and protectin D1 activate inflammation-resolution programmes , 2007, Nature.

[9]  C. Serhan.  Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. , 2007, Annual review of immunology.

[10]  Charles N. Serhan,et al.  Resolvin E1 Selectively Interacts with Leukotriene B4 Receptor BLT1 and ChemR23 to Regulate Inflammation1 , 2007, The Journal of Immunology.

[11]  C. Serhan,et al.  Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression , 2006, Nature Immunology.

[12]  E. Israel,et al.  Agonist-induced lipoxin A4 generation: Detection by a novel lipoxin A4-ELISA , 1993, Lipids.

[13]  J. Wain,et al.  BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation , 2005, The Journal of experimental medicine.

[14]  Megan Sykes,et al.  Organ transplantation—how much of the promise has been realized? , 2005, Nature Medicine.

[15]  Makoto Arita,et al.  Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[16]  B. Levy,et al.  Cyclooxygenase 2 Plays a Pivotal Role in the Resolution of Acute Lung Injury1 , 2005, The Journal of Immunology.

[17]  A. Sher,et al.  Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1 , 2005, The Journal of experimental medicine.

[18]  M. Arnaout,et al.  A synthetic eicosanoid LX‐mimetic unravels host‐donor interactions in allogeneic BMT‐induced GvHD to reveal an early protective role for host neutrophils , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  T. Egan,et al.  Lung transplantation: opportunities for research and clinical advancement. , 2005, American journal of respiratory and critical care medicine.

[20]  J. Wain,et al.  BLT 1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation , 2005 .

[21]  J. A. Badwey,et al.  A Stable Aspirin-Triggered Lipoxin A4 Analog Blocks Phosphorylation of Leukocyte-Specific Protein 1 in Human Neutrophils1 , 2004, The Journal of Immunology.

[22]  A. Haverich,et al.  Contributions from the European Respiratory Monograph Series "lung Transplantation" Edited Immunosuppressive Therapy after Human Lung Transplantation , 2003 .

[23]  C. Serhan,et al.  Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  E. Brambilla,et al.  Alveolar neutrophilia is a predictor for the bronchiolitis obliterans syndrome, and increases with degree of severity. , 2002, Transplant immunology.

[25]  M. Estenne,et al.  Bronchiolitis obliterans after human lung transplantation. , 2002, American journal of respiratory and critical care medicine.

[26]  Eugene Y. Kim,et al.  Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4 , 2002, Nature Medicine.

[27]  O. Levy,et al.  Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[28]  K. Haley,et al.  Prolonged Allograft Survival in TNF Receptor 1-Deficient Recipients Is Due to Immunoregulatory Effects, Not to Inhibition of Direct Antigraft Cytotoxicity1 , 2002, The Journal of Immunology.

[29]  Charles N. Serhan,et al.  Lipid mediator class switching during acute inflammation: signals in resolution , 2001, Nature Immunology.

[30]  R. Buhl,et al.  Induced sputum cell profiles in lung transplant recipients with or without chronic rejection: correlation with lung function , 2001, Thorax.

[31]  Hugh R. Brady,et al.  Cutting Edge: Lipoxins Rapidly Stimulate Nonphlogistic Phagocytosis of Apoptotic Neutrophils by Monocyte-Derived Macrophages1 , 2000, The Journal of Immunology.

[32]  C. Serhan,et al.  HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Anti-Inflammatory Actions of Lipoxin A 4 Stable Analogs Are Demonstrable in Human Whole Blood: Modulation of Leukocyte Adhesion Molecules and Inhibition of Neutrophil-Endothelial Interactions , 2016 .

[33]  C. Serhan,et al.  Lipoxin (LX)A4 and Aspirin-triggered 15-epi-LXA4 Inhibit Tumor Necrosis Factor 1α–initiated Neutrophil Responses and Trafficking: Regulators of a Cytokine–Chemokine Axis , 1999, The Journal of experimental medicine.

[34]  B. Levy,et al.  Polyisoprenyl phosphate (PIPP) signaling regulates phospholipase D activity: a ‘stop’ signaling switch for aspirin‐triggered lipoxin A4 , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  C. Clish,et al.  Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues. , 1998, The Journal of clinical investigation.

[36]  F. Maxfield,et al.  Ca2+- and calcineurin-dependent recycling of an integrin to the front of migrating neutrophils , 1995, Nature.

[37]  C. Schlachta,et al.  Improved techniques for kidney transplantation in mice , 1995, Microsurgery.

[38]  M. Matsubara,et al.  Lipoxygenase product formation and cell adhesion during neutrophil-glomerular endothelial cell interaction. , 1995, The American journal of physiology.

[39]  P. Klotman,et al.  Leukotrienes in renal transplant rejection in rats. Distinct roles for leukotriene B4 and peptidoleukotrienes in the pathogenesis of allograft injury. , 1994, Journal of immunology.

[40]  C. Serhan,et al.  Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers. , 1993, The Journal of clinical investigation.

[41]  C. Klee,et al.  Inhibition of neutrophil chemokinesis on vitronectin by inhibitors of calcineurin. , 1992, Science.

[42]  J. Murray,et al.  Human organ transplantation: background and consequences. , 1992, Science.

[43]  V. Gant,et al.  Identification of lipoxin A4 and its relationship to the sulfidopeptide leukotrienes C4, D4, and E4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases. , 1990, The American review of respiratory disease.

[44]  J. Cooper,et al.  Lung transplantation: opportunities for research and clinical advancement. , 2005, American journal of respiratory and critical care medicine.

[45]  S. Weiss.  Tissue destruction by neutrophils. , 1989, The New England journal of medicine.

[46]  Nobelstiftelsen.  Les Prix Nobel : Nobel Prizes, presentations, biographies and lectures , 1982 .

[47]  John B. Shoven,et al.  I , Edinburgh Medical and Surgical Journal.